Literature DB >> 3889916

Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein.

T Hahn, L Toker, S Budilovsky, D Aderka, Z Eshhar, D Wallach.   

Abstract

Crude preparations of cytotoxins (CTXs) produced by human peripheral blood mononuclear cells exert a marked cytotoxic effect when applied to cells in the presence of cycloheximide but in its absence can induce resistance to cytotoxicity. To examine the relationship between these cytotoxic and protective activities, we attempted to fully dissociate the CTX from the other proteins secreted by mononuclear cells. Mice injected with preparations of the cytokines secreted by peripheral blood mononuclear cells developed significant titers of serum antibodies to CTX(s). Splenocytes of such immunized mice were fused with NSO myeloma cells; a few among the resulting hybridoma cells secreted CTX-binding antibodies. Immunoadsorbents constructed with a monoclonal antibody produced by one of these hybridomas were used to purify to homogeneity a CTX (Mr approximately 17,500) from crude preparations of cytokines, by a single adsorption and elution cycle. Purified CTX was cytotoxic in the presence of cycloheximide but in its absence induced resistance to cytotoxicity; this resistance was manifested by decreased vulnerability to CTX in a subsequent incubation in the presence of cycloheximide. We conclude that CTX itself can induce certain changes in cells, which are reflected in resistance to its own cytotoxic effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889916      PMCID: PMC397878          DOI: 10.1073/pnas.82.11.3814

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  In vitro lymphocyte cytotoxicity. I. Evidence of multiple cytotoxic molecules secreted by mitogen activated human lymphoid cells in vitro.

Authors:  J C Hiserodt; A M Prieur; G A Granger
Journal:  Cell Immunol       Date:  1976-06-15       Impact factor: 4.868

2.  SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.

Authors:  J W LITTLEFIELD
Journal:  Science       Date:  1964-08-14       Impact factor: 47.728

3.  Cytotoxic activity of lymphocytes. IV. Preparation of heterologous antibody to human lymphotoxin.

Authors:  S M Walker; Z J Lucas
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

4.  Early biochemical alterations induced by lymphotoxin in target cells.

Authors:  W Rosenau; M L Goldberg; G C Burke
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

5.  Lymphocyte in vitro cytotoxicity: mechanism of human lymphotoxin-induced target cell destruction.

Authors:  T W Williams; G A Granger
Journal:  Cell Immunol       Date:  1973-02       Impact factor: 4.868

6.  Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction.

Authors:  G A Granger; W P Kolb
Journal:  J Immunol       Date:  1968-07       Impact factor: 5.422

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Susceptibility of human diploid fibroblast strains to transformation by SV40 virus.

Authors:  G J Todaro; H Green; M R Swift
Journal:  Science       Date:  1966-09-09       Impact factor: 47.728

9.  Monoclonal antibodies to human interferon-gamma: production, affinity purification and radioimmunoassay.

Authors:  D Novick; Z Eshhar; D G Fischer; J Friedlander; M Rubinstein
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism.

Authors:  N H Ruddle; B H Waksman
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

View more
  11 in total

1.  Tumor necrosis factor expression in human epithelial tumor cell lines.

Authors:  D R Spriggs; K Imamura; C Rodriguez; E Sariban; D W Kufe
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 2.  The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies.

Authors:  David Wallach
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-10-01       Impact factor: 10.005

Review 3.  Concepts of tissue injury and cell death in inflammation: a historical perspective.

Authors:  David Wallach; Tae-Bong Kang; Andrew Kovalenko
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

4.  Selection of tumor cell variants for resistance to tumor necrosis factor also induces a form of pleiotropic drug resistance.

Authors:  S C Wright; A W Tam; P Kumar
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia.

Authors:  G I Botchkina; M E Meistrell; I L Botchkina; K J Tracey
Journal:  Mol Med       Date:  1997-11       Impact factor: 6.354

6.  Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line.

Authors:  D Spriggs; K Imamura; C Rodriguez; J Horiguchi; D W Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

Review 7.  Tumour necrosis factor and cancer.

Authors:  Frances Balkwill
Journal:  Nat Rev Cancer       Date:  2009-04-03       Impact factor: 60.716

8.  Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer.

Authors:  M Shibata; M Takekawa; S Amano
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

9.  The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells.

Authors:  P J Duerksen-Hughes; T W Hermiston; W S Wold; L R Gooding
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Cytolysis by tumor necrosis factor is preceded by a rapid and specific dissolution of microfilaments.

Authors:  M Scanlon; S M Laster; J G Wood; L R Gooding
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.